<?xml version="1.0" encoding="UTF-8"?>
<ref id="B229-marinedrugs-17-00374" class="ref">
 <label class="label">229.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Lafuente</surname>
    <given-names class="given-names">M.P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Villegas-Perez</surname>
    <given-names class="given-names">M.P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Selles-Navarro</surname>
    <given-names class="given-names">I.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mayor-Torroglosa</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Miralles de Imperial</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Vidal-Sanz</surname>
    <given-names class="given-names">M.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult</article-title>
  <source class="source">Neuroscience</source>
  <year class="year">2002</year>
  <volume class="volume">109</volume>
  <fpage class="fpage">157</fpage>
  <lpage class="lpage">168</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/S0306-4522(01)00458-4</pub-id>
  <?supplied-pmid 11784707?>
  <pub-id pub-id-type="pmid" class="pub-id">11784707</pub-id>
 </element-citation>
</ref>
